Bio

David Kauffmann founded EEP in 1999. He is Chairman of Azanta A/S and a Board Director of AGC Biologics Inc. He also held the position of Chairman of CMC Biologics prior to its successful sale to AGC Japan, and Chairman of the Management Board of Aster Cephac SA. Both at CMC Biologics and at Aster Cephac, he was instrumental in building these two companies over 16 and 10 years, respectively, to international leaders in their industries. David has invested in early stage, development and growth capital, particularly focusing on Healthcare Technology and Pharma Services companies. Previously to EEP, he was a Junior Partner at CAI Capital Management Co., a Private Equity fund with offices in New York and Vancouver. Prior to working in Private Equity and Venture Capital, David worked for American Express Bank in London, New York and Copenhagen. He holds an MBA from IMD in Lausanne, Switzerland, and a BSc from the Copenhagen School of Economics and Business Administration.